BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2124241)

  • 1. Transformation of T lymphocytes by the v-fos oncogene.
    Valge-Archer VE; de Villiers J; Sinskey AJ; Rao A
    J Immunol; 1990 Dec; 145(12):4355-64. PubMed ID: 2124241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct signals are required for proliferation and lymphokine gene expression in murine T cell clones.
    Heckford SE; Gelmann EP; Agnor CL; Jacobson S; Zinn S; Matis LA
    J Immunol; 1986 Dec; 137(11):3652-63. PubMed ID: 3097128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costimulation of peripheral blood T cell activation by human endothelial cells. Enhanced IL-2 transcription correlates with increased c-fos synthesis and increased Fos content of AP-1.
    Hughes CC; Pober JS
    J Immunol; 1993 Apr; 150(8 Pt 1):3148-60. PubMed ID: 8468462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human T-cell leukemia virus type 1 tax protein activates transcription through AP-1 site by inducing DNA binding activity in T cells.
    Iwai K; Mori N; Oie M; Yamamoto N; Fujii M
    Virology; 2001 Jan; 279(1):38-46. PubMed ID: 11145887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirements for the simultaneous presence of phorbol esters and calcium ionophores in the expression of human T lymphocyte proliferation-related genes.
    Kumagai N; Benedict SH; Mills GB; Gelfand EW
    J Immunol; 1987 Sep; 139(5):1393-9. PubMed ID: 3114365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of nuclear proto-oncogenes in T cells triggered with mitogenic and nonmitogenic T3 and T11 activation signals.
    Shipp MA; Reinherz EL
    J Immunol; 1987 Oct; 139(7):2143-8. PubMed ID: 2821108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
    Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
    Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proto-oncogene expression in cloned T lymphocytes: mitogens and growth factors induce different patterns of expression.
    Reed JC; Alpers JD; Scherle PA; Hoover RG; Nowell PC; Prystowsky MB
    Oncogene; 1987 May; 1(2):223-8. PubMed ID: 3501855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-CD3 antibody induces rapid expression of cytokine genes in vivo.
    Scott DE; Gause WC; Finkelman FD; Steinberg AD
    J Immunol; 1990 Oct; 145(7):2183-8. PubMed ID: 2144547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-fos is a positive regulator of carcinogen enhancement of adenovirus transformation.
    Su ZZ; Yemul S; Stein CA; Fisher PB
    Oncogene; 1995 May; 10(10):2037-49. PubMed ID: 7761104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of anti-proliferative cyclic AMP on interleukin 2-stimulated gene expression.
    Farrar WL; Evans SW; Rapp UR; Cleveland JL
    J Immunol; 1987 Sep; 139(6):2075-80. PubMed ID: 3040863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of c-myc and other genes in interleukin 2 regulated CT6 T lymphocytes and their malignant variants.
    Cleveland JL; Rapp UR; Farrar WL
    J Immunol; 1987 May; 138(10):3495-504. PubMed ID: 3106484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of revertant cell lines to identify targets of v-fos transformation-specific alterations in gene expression.
    Hoemann CD; Zarbl H
    Cell Growth Differ; 1990 Dec; 1(12):581-90. PubMed ID: 2126949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-12-induced activation of NK and T cells occurs in the absence of immediate-early activation gene expression.
    Azzoni L; Kanakaraj P; Zatsepina O; Perussia B
    J Immunol; 1996 Oct; 157(8):3235-41. PubMed ID: 8871617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1.
    Heikkila R; Schwab G; Wickstrom E; Loke SL; Pluznik DH; Watt R; Neckers LM
    Nature; 1987 Jul 30-Aug 5; 328(6129):445-9. PubMed ID: 3302722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired induction of c-fos/c-jun genes and of transcriptional regulatory proteins binding distinct c-fos/c-jun promoter elements in activated human T cells during aging.
    Whisler RL; Chen M; Beiqing L; Carle KW
    Cell Immunol; 1997 Jan; 175(1):41-50. PubMed ID: 9015187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between Raf and Myc oncogenes in transformation in vivo and in vitro.
    Cleveland JL; Jansen HW; Bister K; Fredrickson TN; Morse HC; Ihle JN; Rapp UR
    J Cell Biochem; 1986; 30(3):195-218. PubMed ID: 3084503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-2-dependent proliferation of murine T cells requires expression of both the p55 and p70 subunits of the IL-2 receptor.
    Jankovic DL; Rebollo A; Kumar A; Gibert M; Thèze J
    J Immunol; 1990 Dec; 145(12):4136-44. PubMed ID: 2258612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. v-FBR-fos oncogene fails to rescue mammalian cells from growth arrest but affects the responses of human fibroblasts to heparin.
    Kolettas E; Evangelou A; Gonos ES
    Anticancer Res; 2001; 21(1A):435-44. PubMed ID: 11299775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of c-fos and c-myc expression during B cell activation by IL-4 and immunoglobulin binding ligands.
    Klemsz MJ; Justement LB; Palmer E; Cambier JC
    J Immunol; 1989 Aug; 143(3):1032-9. PubMed ID: 2787345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.